The cyanobacterial vaccine has proven to be very effective in Latin America

The cyanobacterial vaccine has proven to be very effective in Latin America
Montevideo: The South American country of Uruguay on Tuesday released real data on the spectacular effects of the Chinese corona vaccine Synovik and the vaccine from the American and German companies Pfizer and Biotech.

According to the report, Uruguay, while presenting the data related to Synovik’s corona vaccine, said that this vaccine has proved to be 90% effective in preventing hospital admissions and deaths in the case of severe illness in their people.

According to the data, the Chinese vaccine has reduced the number of deaths by 95% and hospital admissions by 92% in case of serious illness, while it has also shown a 61% benefit in eradicating coronary infections.

According to the report, the actual data on the efficacy of the vaccine were compared with those who had not been vaccinated, compared with those who were given both doses of the vaccine, and at least 14 times more than the second dose. The day after, vaccine recipients included healthcare workers and the general public, ranging in age from 18 to 69.

The Uruguayan government also studied the Pfizer / Biotech vaccine, which looked at 162,000 health workers and the general public, who were up to 80 years old. The vaccine has been shown to be 94% effective in preventing hospital admissions in cases of death and serious illness, and its use has reduced the number of infections by 78%.

According to the official report, more than 90% of the citizens who were fully vaccinated saw a decrease in deaths and hospital admissions due to serious illness.

It should be noted that this small Latin country with a population of 3.5 million has largely controlled the Corona epidemic through severe lockdowns last year, but this year has seen a sharp rise in Corona cases and in recent weeks Uruguay Coronavirus was one of the top countries in terms of the number of people dying from the virus (per million population).

At least 52% of Uruguay’s population has so far received at least one dose of the coronavirus vaccine, while the vaccines include Cyanovik, Pfizer Bio-N Tech, and AstraZeneca, which are administered to the country through covacs. Were found So far, only 29% of the population has been fully vaccinated.